{"id":24551,"date":"2025-01-17T13:50:03","date_gmt":"2025-01-17T18:50:03","guid":{"rendered":"https:\/\/www.med.unc.edu\/pharm\/?p=24551"},"modified":"2025-01-27T13:01:58","modified_gmt":"2025-01-27T18:01:58","slug":"laura-peng-and-yi-xu-publish-article-in-cancer-discovery","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/pharm\/laura-peng-and-yi-xu-publish-article-in-cancer-discovery\/","title":{"rendered":"Laura Peng and Yi Xu publish article in Cancer Discovery"},"content":{"rendered":"
Congratulations to Dr.\u00a0Laura Peng<\/b>, PhD\u00a0<\/b>and Yi Xu<\/b>, PhD, working in the lab of Jen Jen Yeh<\/b>, MD,\u00a0on their groundbreaking findings published in Cancer Discovery<\/i>!<\/p>\n Xu and Peng’s work identified distinct “kinotypes” in pancreatic ductal adenocarcinoma (PDAC), offering critical insights into the basal-like and classical subtypes of this challenging cancer. This remarkable achievement exemplifies the power of innovative research to drive advancements in cancer therapy and improve patient outcomes.<\/p>\n<\/a>